Two renewed electronic catalogues of real-world data (RWD) sources and studies to enhance data discoverability have recently been launched by EMA and Heads of Human Medicines.
? The Catalogue of RWD Sources replaces the ENCePP Resources Database, offering a centralised repository […]
Welcome to the team Raphaela Mayerhofer, PhD.
Raphaela joins the RWE team in Stockholm following a career at Karolinska Institutet, Södertörn University, and the Medizinische Universität Graz, amongst others.
Alongside her academic career Raphaela […]
· ???? ?? ???
JCA is a streamlined EU-level process that evaluates the relative effectiveness and safety of new treatments compared to a range of alternative treatments. It considers a range of relevant treatments across EU member states. The resulting JCA report […]
Quantify is proud to introduce Ana Buzatu, who will support our Model, Access, and Strategy team in Stockholm as a Junior Research Analyst.
Ana is a pharmacist currently pursuing a master’s degree in Health economics, Policy and Management at […]
Make sure you’ve read Quantify’s CEO Kirk Geale‘s PharmaTimes article published late last year, explaining how global pharmaceutical executives can harness the power of Scandinavian health data to achieve regulatory and commercial success.
BCG has prepared a report pointing to five main areas for improvement in the Norwegian real-world data landscape:
1. Performing holistic mapping of the process of accessing health data to identify bottlenecks and inform future priorities for progress
2. Clarifying and adapting the […]
As the number one provider of Nordic registry studies, Quantify sits at the heart of Scandinavia.
The Nordics typically refers to Northern European countries with similar history, culture and social structures.
They include Denmark, Finland, Iceland, Norway and Sweden plus some autonomous […]
It’s been a great day at SCOPE summit! In addition to joining in many excellent seminars, we’ve had a great exchange of ideas about how Nordic data can support regulatory decision making and clinical development objectives.
Come visit us tomorrow at […]
Quantify’s Partner Anders Gustavsson and other Alzheimer’s experts recently shared their perspectives after a symposium at Karolinska Institutet.
Preparing for the introduction of disease modifying treatments in Alzheimer’s disease implies several challenges to patient identification, treatment […]
Don’t miss it!
Next week, Quantify’s CEO Kirk Geale and Head of RWE Emilie Toresson Grip are headed to Orlando, FL for the annual SCOPE Summit where the Quantify […]